These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26794390)

  • 41. Cross-cultural validation of the UCLA prostate cancer index.
    Karakiewicz PI; Kattan MW; Tanguay S; Elhilali MM; Bazinet M; Scardino PT; Aprikian AG
    Urology; 2003 Feb; 61(2):302-7. PubMed ID: 12597935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expanded Prostate Cancer Index Composite-26 (EPIC-26) Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life After Treatment for Localized Prostate Cancer.
    Einstein DJ; Patil D; Chipman J; Regan MM; Davis K; Crociani CM; Wagner AA; Sanda MG; Chang P
    Urology; 2019 May; 127():53-60. PubMed ID: 30790648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating peer support for prostate cancer: the Prostate Cancer Peer Support Inventory.
    Steginga SK; Pinnock C; Gardner M; Gardiner RA; Dunn J
    BJU Int; 2005 Jan; 95(1):46-50. PubMed ID: 15663527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Global Quality of Life After Curative Treatment for Prostate Cancer: What Matters? A Study Among Members of the Norwegian Prostate Cancer Patient Association.
    Fosså SD; Dahl AA
    Clin Genitourin Cancer; 2015 Dec; 13(6):518-24. PubMed ID: 26303590
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction.
    Kimura M; Bañez LL; Polascik TJ; Bernal RM; Gerber L; Robertson CN; Donatucci CF; Moul JW
    Andrology; 2013 Mar; 1(2):256-61. PubMed ID: 23413138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and validation of a quality-of-life measure for men with nocturia.
    Abraham L; Hareendran A; Mills IW; Martin ML; Abrams P; Drake MJ; MacDonagh RP; Noble JG
    Urology; 2004 Mar; 63(3):481-6. PubMed ID: 15028442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disease-specific quality of life among patients with localized prostate cancer: an Australian perspective.
    Newton FJ; Burney S; Millar JL; Frydenberg M; Ng KT
    BJU Int; 2006 Jun; 97(6):1179-83. PubMed ID: 16686708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health-related quality of life and treatment outcomes for men with prostate cancer treated by combined external-beam radiotherapy and hormone therapy.
    Hashine K; Azuma K; Koizumi T; Sumiyoshi Y
    Int J Clin Oncol; 2005 Feb; 10(1):45-50. PubMed ID: 15729601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of oncological and health-related quality of life outcomes between open and robot-assisted radical prostatectomy for localised prostate cancer - findings from the population-based Victorian Prostate Cancer Registry.
    Ong WL; Evans SM; Spelman T; Kearns PA; Murphy DG; Millar JL
    BJU Int; 2016 Oct; 118(4):563-9. PubMed ID: 26573954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Responsiveness of the University of California-Los Angeles Prostate Cancer Index.
    Bergman J; Saigal CS; Kwan L; Litwin MS
    Urology; 2010 Jun; 75(6):1418-23. PubMed ID: 19589573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostate cancer and health-related quality of life: a review of the literature.
    Eton DT; Lepore SJ
    Psychooncology; 2002; 11(4):307-26. PubMed ID: 12203744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
    Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of comorbidities and socioeconomic status on sexual and urinary function in men undergoing prostate cancer screening.
    Bhojani N; Perrotte P; Jeldres C; Suardi N; Hutterer G; Shariat SF; Karakiewicz PI
    J Sex Med; 2008 Mar; 5(3):668-76. PubMed ID: 18221289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings.
    Giesler RB; Miles BJ; Cowen ME; Kattan MW
    Qual Life Res; 2000; 9(6):645-65. PubMed ID: 11236855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer.
    Coen JJ; Paly JJ; Niemierko A; Weyman E; Rodrigues A; Shipley WU; Zietman AL; Talcott JA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e201-9. PubMed ID: 21621343
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measuring self-reported sexual function in men with prostate cancer.
    Brucker PS; Cella D
    Urology; 2003 Oct; 62(4):596-606. PubMed ID: 14550425
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer.
    Tavlarides AM; Ames SC; Diehl NN; Joseph RW; Castle EP; Thiel DD; Broderick GA; Parker AS
    Psychooncology; 2013 Jun; 22(6):1328-35. PubMed ID: 22855322
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Obesity does not adversely affect health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy.
    Freedland SJ; Haffner MC; Landis PK; Saigal CS; Carter HB
    Urology; 2005 Jun; 65(6):1131-6. PubMed ID: 15913722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.
    Wei JT; Dunn RL; Sandler HM; McLaughlin PW; Montie JE; Litwin MS; Nyquist L; Sanda MG
    J Clin Oncol; 2002 Jan; 20(2):557-66. PubMed ID: 11786586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quality of life 2 years after salvage cryosurgery for the treatment of local recurrence of prostate cancer after radiotherapy.
    Robinson JW; Donnelly BJ; Coupland K; Siever JE; Saliken JC; Scott C; Brasher PM; Ernst DS
    Urol Oncol; 2006; 24(6):472-86. PubMed ID: 17138127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.